Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Single-dose, Dose-escalation Study of Safety, PK, and Preliminary Efficacy of XOMA 052 in Type 2 Diabetes Mellitus

This study has been completed.
Information provided by:
XOMA (US) LLC Identifier:
First received: October 8, 2007
Last updated: May 2, 2010
Last verified: May 2010